CHRISTOPHER DEONARINE: Open Payments
NPI 1629455373 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 6 payments from 3 companies in 2025. Trend: 2023 $498 · 2024 $491 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 3 | $160 |
| Medline Industries LP | 2 | $56 |
| ABIOMED | 1 | $41 |
Products named: FIBRYGA.
Industry payments across TX — which companies pay providers there.
